Lung function and oxygen saturation after participation in Norseman Xtreme Triathlon. (19th March 2020)

• Record Type: Journal Article
• Authors: Stensrud, Trine; Rossvoll, Øyvind; Mathiassen, Maria; Melau, Jørgen; Illidi, Camilla; Østgaard, Hege N.; Hisdal, Jonny; Stang, Julie
• Is Part Of: Scandinavian journal of medicine & science in sports. Volume 30:Number 6(2020)
• Page Start: 1008
• Page End: 1016
• Publication Date: 2020-03-19
• Subjects: exercise‐induced arterial hypoxemia -- exercise‐induced bronchoconstriction -- triathletes; Sports medicine -- Periodicals; Sports -- Physiological aspects -- Periodicals; Sports -- Periodicals; 617.1027
• DOI: 10.1111/sms.13651
• Languages: English
• ISSNs: 0905-7188

Abstract

Abstract : Objectives: To examine evidence of exercise‐induced bronchoconstriction (EIB) defined as ≥10% reduction in forced expiratory volume in one second (FEV1 ) and exercise‐induced arterial hypoxemia (EIAH) defined as ≥4% reduction in oxygen saturation (SpO2 ) from before to after participation in the Norseman Xtreme Triathlon. Secondarily, to assess whether changes in FEV1 and SpO2 are related to respiratory symptoms, training volume, and race time. Methods: In this quasi‐experimental non‐controlled study, we included 63 triathletes (50♂/13♀) aged 40.3 (±9.0) years (mean ± SD). Fifty‐seven (46♂/11♀) measured lung function and 54 (44♂/10♀) measured SpO2 before the race, 8‐10 minutes after the race (post‐test 1) and the day after the race (post‐test 2). Respiratory symptoms and training volume were recorded with modified AQUA questionnaire. ANOVA for repeated measures was used to detect differences in lung function and SpO2 . Statistical significance was accepted at 0.05 level. Results: Twenty‐six participants (46%) presented with EIB at post‐test 1 and 16 (28%) at post‐test 2. Lung function variables were significantly reduced from baseline to post‐test 1 and 2. Thirty‐five participants (65%) showed evidence of mild to moderate EIAH. No significant correlations were observed except a weak correlation between maximal reduction in FEV1 and respiratory symptoms (r = 0.35, P = .016). Conclusion: Our results demonstrated that 46% of the participants presented with EIB and 65% showed evidence of EIAH after the Norseman Xtreme Triathlon. Changes in FEV1 and SpO2 were not correlated to weekly training hours or race time. We observed a weak correlation between maximal reduction in FEV1 and respiratory symptoms.